Activation of NF-kappaB and c-jun transcription factors in multiple sclerosis lesions. Implications for oligodendrocyte pathology.

[1]  E. Coccia,et al.  Synergistic stimulation of MHC class I and IRF‐1 gene expression by IFN‐γ and TNF‐α in oligodendrocytes , 1998, The European journal of neuroscience.

[2]  M. Chao,et al.  Competitive Signaling Between TrkA and p75 Nerve Growth Factor Receptors Determines Cell Survival , 1998, The Journal of Neuroscience.

[3]  P. Barker,et al.  p75 Neurotrophin Receptor Expression on Adult Human Oligodendrocytes: Signaling without Cell Death in Response to NGF , 1998, The Journal of Neuroscience.

[4]  J. Newcombe,et al.  Transcription factor NF-kappaB and inhibitor I kappaBalpha are localized in macrophages in active multiple sclerosis lesions. , 1998, Journal of neuropathology and experimental neurology.

[5]  C. Raine,et al.  Multiple sclerosis: Oligodendrocytes display cell death–related molecules in situ but do not undergo apoptosis , 1997, Annals of neurology.

[6]  C. Kaltschmidt,et al.  NF-kB: a crucial transcription factor for glial and neuronal cell function , 1997, Trends in Neurosciences.

[7]  T. Herdegen,et al.  The c-Jun transcription factor – bipotential mediator of neuronal death, survival and regeneration , 1997, Trends in Neurosciences.

[8]  J. Antel,et al.  Multiple Sclerosis: Fas Signaling in Oligodendrocyte Cell Death , 1996, The Journal of experimental medicine.

[9]  David Baltimore,et al.  An Essential Role for NF-κB in Preventing TNF-α-Induced Cell Death , 1996, Science.

[10]  Marty W. Mayo,et al.  TNF- and Cancer Therapy-Induced Apoptosis: Potentiation by Inhibition of NF-κB , 1996, Science.

[11]  R. Davis,et al.  Textbook of Neuropathology , 1996 .

[12]  Seamus J. Martin,et al.  Suppression of TNF-α-Induced Apoptosis by NF-κB , 1996, Science.

[13]  Michael Karin,et al.  Dissection of TNF Receptor 1 Effector Functions: JNK Activation Is Not Linked to Apoptosis While NF-κB Activation Prevents Cell Death , 1996, Cell.

[14]  David Baltimore,et al.  NF-κB: Ten Years After , 1996, Cell.

[15]  S. Rosenzweig,et al.  Activation of C‐jun N‐terminal kinase/stress‐activated protein kinase in primary glial cultures , 1996, Journal of neuroscience research.

[16]  Moses Rodriguez,et al.  Distinct Patterns of Multiple Sclerosis Pathology Indicates Heterogeneity in Pathogenesis , 1996, Brain pathology.

[17]  H. Lassmann,et al.  Apoptosis in brain-specific autoimmune disease , 1995, Current Opinion in Immunology.

[18]  C. Goodyer,et al.  Differential susceptibility of human CNS-derived cell populations to TNF-dependent and independent immune-mediated injury , 1995, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[19]  D. Griffin,et al.  In vitro evidence for a dual role of tumor necrosis factor‐α in human immunodeficiency virus type 1 encephalopathy , 1995, Annals of neurology.

[20]  Christian Kaltschmidt,et al.  Transcription factor NF-κB is activated in microglia during experimental autoimmune encephalomyelitis , 1994, Journal of Neuroimmunology.

[21]  J. Woodgett,et al.  The stress-activated protein kinase subfamily of c-Jun kinases , 1994, Nature.

[22]  M. Cuzner,et al.  Cytokine mRNA expression in inflammatory multiple sclerosis lesions: detection by non-radioactive in situ hybridization. , 1993, Cytokine.

[23]  J. Louis,et al.  CNTF protection of oligodendrocytes against natural and tumor necrosis factor-induced death , 1993, Science.

[24]  C. Brosnan,et al.  Identification of lymphotoxin and tumor necrosis factor in multiple sclerosis lesions. , 1991, The Journal of clinical investigation.

[25]  J. Merrill,et al.  Tumor necrosis factor identified in multiple sclerosis brain , 1989, The Journal of experimental medicine.

[26]  K. Selmaj,et al.  Tumor necrosis factor mediates myelin and oligodendrocyte damage in vitro , 1988, Annals of neurology.

[27]  C. Raine.  The Dale E. McFarlin memorial lecture: The immunology of the multiple sclerosis lesion , 1994, Annals of neurology.

[28]  M. Grilli,et al.  NF-kappa B and Rel: participants in a multiform transcriptional regulatory system. , 1993, International review of cytology.